Syndax Pharmaceuticals SNDX Earnings Call Transcripts

NASDAQ SNDX
$9.49 -0.06 (-0.63%)
At close: Nov 10, 2026 · 4:00 PM EST
4 earnings calls on file for Syndax Pharmaceuticals, from Q1 2020 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Syndax Pharmaceuticals Q3 2026 Earnings Call

Nov 2, 2026 10,265 words · 45 min read
  • Sharon KlahreHead of Investor Relations
  • Michael MetzgerChief Executive Officer
  • Steven ClosterChief Commercial Officer
  • Dr. Nick BotwoodHead of R&D and Chief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Syndax Pharmaceuticals Earnings Call Transcripts

Calls4
LatestNov 2, 2026
SinceQ1 2020

Fiscal 2026

Fiscal 2025

Fiscal 2020

All 4 Syndax Pharmaceuticals transcripts Register to get access to Syndax Pharmaceuticals’s earnings call transcripts.